IR
USNA icon

Invictus RG’s Usana Health Sciences USNA Stock Holding History

Invictus RG’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,459
Closed -$212K – 839
2016
Q4 		$212K Buy
+3,459
New +$225K 0.14% 300
2016
Q3 		– Sell
-2,162
Closed -$120K – 808
2016
Q2 		$120K Sell
2,162
-5,074
-70% -$306K 0.13% 275
2016
Q1 		$439K Buy
7,236
+7,162
+9,678% +$422K 0.53% 39
2015
Q4 		$5K Buy
+74
New +$4.8K ﹤0.01% 583

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Invictus RG's USNA Position: Q1 2017 in Review

Invictus RG sold out of Usana Health Sciences (USNA) in Q1 2017, closing a stake of 3,459 shares — an estimated $212K sold.

Invictus RG first reported a position in USNA in Q4 2015 and held it in 4 quarters. The position peaked at $439K in Q1 2016. 155 funds tracked by Wall St. Rank hold USNA as of Q1 2017.

  • Invictus RG reported no remaining Usana Health Sciences position as of Q1 2017 after selling out during the quarter.
  • Invictus RG sold 3,459 Usana Health Sciences shares in Q1 2017, an estimated $212K.
  • Invictus RG first reported a position in Usana Health Sciences in Q4 2015 and held it in 4 quarters.
  • Invictus RG's Usana Health Sciences position peaked at $439K in Q1 2016.
  • 155 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2017.

Based on Invictus RG's 13F filing for Q1 2017, filed 12 May 2017.